What does Rakesh Jhunjhunwala see in Jubilant Life Sciences?
Within a year, the investing legend has doubled down on his latest pharma bet
Himanshu Kakkar - May 23, 2020
The Outperformers (41-50)
These companies have been ranked based on their stock's excess return over the Sensex for a five-year period
August 28, 2019